Eileen Rice
Neurology · Pittsburgh, PANPI 1548357247
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Acorda Therapeutics, Inc at 52.7% of the total. Reporting peaked in 2019 at $32,855 and has fallen 97.9% since, to $678 in 2023.
Across 146 payments — averaging $257.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acorda Therapeutics, Inc$20K
- Sanofi$6K
- Teva Pharmaceuticals USA, Inc.$6K
- Livanova USA, Inc.$1K
- AbbVie$654
- Avanir Pharmaceuticals, Inc.$599
- plus $4K from 19 others
What the payments were for
- Consulting fees$5,91616%
- Speaking & faculty fees$19,42552%
- Travel & lodging$2,7197%
- Food & beverage$9,49525%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acorda Therapeutics, Inc | 34 | $19,778 |
| Sanofi | 25 | $5,889 |
| Teva Pharmaceuticals USA, Inc. | 15 | $5,717 |
| Livanova USA, Inc. | 8 | $1,266 |
| AbbVie(2 entities) | 8 | $654 |
| Avanir Pharmaceuticals, Inc. | 6 | $599 |
| EMD Serono, Inc. | 4 | $457 |
| Amgen | 4 | $432 |
| Mallinckrodt Enterprises LLC | 3 | $354 |
| Novartis | 7 | $350 |
| MDD US Operations, LLC | 3 | $263 |
| UCB, Inc. | 6 | $261 |
| Lundbeck LLC | 4 | $251 |
| Acadia Pharmaceuticals Inc | 3 | $247 |
| Abbott | 2 | $144 |
| Tanabe Pharma America, Inc. | 1 | $126 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Genentech USA, Inc. | 1 | $119 |
| SK Life Science, Inc. | 1 | $117 |
| Amneal Pharmaceuticals LLC | 1 | $106 |
| Jazz Pharmaceuticals Inc. | 1 | $101 |
| Supernus Pharmaceuticals, Inc. | 5 | $78 |
| Mallinckrodt Hospital Products Inc. | 1 | $68 |
| Biogen | 1 | $30 |
| Adamas Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INBRIJA$18,852
- AJOVY$5,175
- DISEASE STATE$3,880
- VNS Therapy$1,074
- NUEDEXTA$488
- ACTHAR$354
- AUSTEDO$346
- UBRELVY$342
- AIMOVIG$335
- Mavenclad$246
- APOKYN$237
- NUPLAZID$229
- AUBAGIO$216
- GILENYA$209
- Radicava$126
- Briviact$125
- NURTEC ODT$125
- Xadago$122
- Infinity DBS Pulse Generators$119
- OCREVUS$119
How this compares
$37,554 in reported general payments places this provider in the 85th percentile of 941 neurology providers in Pennsylvania.
Other neurology in Pittsburgh
- Anoopum GuptaPittsburgh$592K
- Thomas ScottPittsburgh$476K
- James ValerianoPittsburgh$416K
- Amber van LaarPittsburgh$413K
- Andrea SynowiecPittsburgh$386K
- Dolores Dominguez SantamariaPittsburgh$265K
- Heather MouryPittsburgh$186K
- Troy DesaiPittsburgh$174K
- Richard KasdanPittsburgh$172K
- David LobasPittsburgh$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.